Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Société des Produits Nestlé S.A. › 18703803
Last updated: April 22, 2026
Application No. 18/703,803

Untitled Application

Unknown
Filed
1600
Priority
Oct 27, 2021 — EU 21205112.2 +1 more
Examiner
HOFFMAN, SUSAN COE
Art Unit
1655
Tech Center
SOCIETE DES PRODUITS NESTLE S.A.
Assignee
Société des Produits Nestlé S.A.
OA Round
1 (Non-Final)
54%
Grant Probability
Moderate
1-2
OA Rounds
2y 11m
Filing → Grant
80%
With Interview

This examiner grants 54% of cases after interview

— +25.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.
Based on 1058 resolved cases, 2023–2026

Examiner Intelligence

HOFFMAN, SUSAN COE View full profile →
Grants 54% of resolved cases
54%
Career Allowance Rate
572 granted / 1058 resolved
-5.9% vs TC avg
Strong +26% interview lift
Without
With
+25.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
67 currently pending
Career history
1125
Total Applications
across all art units

Statute-Specific Performance

§101
9.5%
-30.5% vs TC avg
§103
34.9%
-5.1% vs TC avg
§102
17.4%
-22.6% vs TC avg
§112
26.9%
-13.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1058 resolved cases

Prosecution Timeline

1600
Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/130,765
Patent 12594313
COMPOSITION FOR RELIEVING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS COMPRISING A MIXED EXTRACT OF HOP AND CYNANCHUM WILFORDII AND METHOD FOR TREATING OR ALLEVIATING CARDIOVASCULAR DISEASES OR OSTEOPOROSIS USING THE SAME
3y 0m to grant Granted Apr 07, 2026
18/152,140
Patent 12582674
Methods and Treatment of Trauma
3y 2m to grant Granted Mar 24, 2026
18/012,808
Patent 12569527
TETRASELMIS CHUII (T. CHUII) FOR THE TREATMENT OF MALE INFERTILITY
3y 2m to grant Granted Mar 10, 2026
17/296,301
Patent 12564606
PHARMACEUTICAL COMPOSITION FOR TREATING WOUNDS
4y 9m to grant Granted Mar 03, 2026
17/909,333
Patent 12564551
Composition or oat extract comprising avenanthramide and ß-glucan
3y 6m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
54%
Grant Probability
80%
With Interview (+25.7%)
2y 11m
Median Time to Grant
Low
PTA Risk
Based on 1058 resolved cases by this examiner. Grant probability derived from career allowance rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month